Drug interactions with herbal products and grapefruit juice: A conference report

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Clinical pharmacology and therapy

• Publication date

  2004-01-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.clpt.2003.07.002PMID 14749688
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Unwanted pregnancy on self-medication with St John's wort despite hormonal contraception.

  2008cited by this paper
• Alterations in cyclosporin A pharmacokinetics and metabolism during treatment with St John's wort in renal transplant patients.

  2003cited by this paper
• インターネットで読むFDA情報(27)植物製品のガイダンス(2)Guidance for Industry: Botanical Drug Products

  2003cited by this paper
• The effect of echinacea on CYP3A activity in vivo

  2003cited by this paper
• Methadone maintenance treatment and St. John's Wort - a case report.

  2003cited by this paper
• Recent patterns of medication use in the ambulatory adult population of the United States: the Slone survey.

  2002cited by this paper
• Tacrolimus-induced nephrotoxicity unmasked by induction of the CYP3A4 system with St John's wort.

  2002cited by this paper
• Utilization of Complementary and Alternative Medicine by United States Adults: Results From the 1999 National Health Interview Survey

  2002cited by this paper
• Effect of St John's wort on the pharmacokinetics of fexofenadine

  2002cited by this paper
• Fruit juices inhibit organic anion transporting polypeptide–mediated drug uptake to decrease the oral availability of fexofenadine

  2002cited by this paper
• Decreased Plasma Levels of Amitriptyline and Its Metabolites on Comedication With an Extract From St. John’s Wort (Hypericum perforatum)

  2002cited by this paper
• Are herbal products dietary supplements or drugs? An important question for public safety

  2002cited by this paper
• Different effects of St John's Wort on the pharmacokinetics of simvastatin and pravastatin

  2001cited by this paper
• The effects of St John's wort (Hypericum perforatum) on human cytochrome P450 activity

  2001cited by this paper
• Complementary and alternative medicine use in children

  2001cited by this paper
• Long-Term Trends in the Use of Complementary and Alternative Medical Therapies in the United States

  2001cited by this paper
• Adverse cardiovascular and central nervous system events associated with dietary supplements containing ephedra alkaloids.

  2001cited by this paper
• Seville orange juice‐felodipine interaction: Comparison with dilute grapefruit juice and involvement of furocoumarins

  2001cited by this paper
• Reimbursement for complimentary/alternative medicine by California HMOs.

  2001cited by this paper
• Indinavir concentrations and St John's wort.

  2000cited by this paper
• Safety of St John's wort (Hypericum perforatum)

  2000cited by this paper
• Alternative Medicine Use in Older Americans

  2000cited by this paper
• St John's Wort induces intestinal P‐glycoprotein/MDR1 and intestinal and hepatic CYP3A4

  2000cited by this paper
• St John's Wort: Effect on CYP3A4 activity

  2000cited by this paper
• Acute heart transplant rejection due to Saint John's wort.

  2000cited by this paper
• St. John's wort induces hepatic drug metabolism through activation of the pregnane X receptor.

  2000cited by this paper
• Safety of St John's wort (Hypericum perforatum)

  2000cited by this paper
• Population-Based Survey of Complementary and Alternative Medicine Usage, Patient Satisfaction, and Physician Involvement

  2000cited by this paper
• St John's Wort: effect on CYP3A4 activity.

  2000cited by this paper
• Pentamidine-Induced Hemolytic Anemia in an AIDS Patient

  1999cited by this paper
• Influence of grapefruit juice on cisapride pharmacokinetics

  1999cited by this paper
• The Complete German Commission E Monographs

  1999cited by this paper
• Potential Metabolic Interaction between St. John's Wort and Theophylline

  1999cited by this paper
• Pharmacokinetic interaction of digoxin with an herbal extract from St John's wort (Hypericum perforatum)

  1999cited by this paper
• Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions.

  1998cited by this paper
• Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey.

  1998influential reference
• Why patients use alternative medicine: results of a national study.

  1998cited by this paper
• Why patients use alternative medicine.

  1998cited by this paper
• Grapefruit juice-drug interactions.

  1998cited by this paper
• Why patients use alternative medicine.

  1998cited by this paper
• Book Reviews

  1998cited by this paper
• Oral contraceptive discontinuation: a prospective evaluation of frequency and reasons.

  1998cited by this paper
• Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression.

  1997influential reference
• Mechanisms of enhanced oral availability of CYP3A4 substrates by grapefruit constituents. Decreased enterocyte CYP3A4 concentration and mechanism-based inactivation by furanocoumarins.

  1997influential reference
• Uptake of alternative medicine.

  1996cited by this paper
• Uptake of alternative medicine

  1996cited by this paper
• Identification of 6',7'-dihydroxybergamottin, a cytochrome P450 inhibitor, in grapefruit juice.

  1996cited by this paper
• Interaction of citrus juices with felodipine and nifedipine.

  1991cited by this paper
• Effect of brussels sprouts and cabbage on drug conjugation

  1984cited by this paper
• Stimulatory effect of brussels sprouts and cabbage on human drug metabolism

  1979cited by this paper

• Polyphenols synergistic drugs to ameliorate non-alcoholic fatty liver disease via signal pathway and gut microbiota: A review

  2024cites this paper
• Physiologically Based Pharmacokinetic Modeling of Bergamottin and 6,7‐Dihydroxybergamottin to Describe CYP3A4 Mediated Grapefruit‐Drug Interactions

  2023cites this paper
• Knowledge and perceptions about food and drug interactions: A survey among second year medical undergraduate students in a government medical college in southern India

  2021cites this paper
• Drug Metabolism: Cytochrome P450

  2021cites this paper
• Phytochemical and Over-The-Counter Drug Interactions: Involvement of Phase I and II Drug-Metabolizing Enzymes and Phase III Transporters

  2021influential citation
• Mango (Mangifera indica L.) Polyphenols: Anti-Inflammatory Intestinal Microbial Health Benefits, and Associated Mechanisms of Actions

  2021cites this paper
• Citrus auraptene induces drug efflux transporter P-glycoprotein expression in human intestinal cells.

  2020cites this paper
• Az időskori gyógyszerterápia alapjai

  2019cites this paper
• Phyto-Pharmaceuticals, Nutraceuticals and Their Evaluation

  2019cites this paper
• Safety-Related Quality Issues for the Development of Herbal Drugs

  2019cites this paper
• Sex-specific modulation of drug bioavailability with pharmaceutical excipients

  2018cites this paper
• Factors to Consider in Development of Nutraceutical and Dietary Supplements

  2017cites this paper
• Association of fl avonoid-rich foods and fl avonoids with risk of all-cause mortality

  2017cites this paper
• Association of flavonoid-rich foods and flavonoids with risk of all-cause mortality

  2017cites this paper
• Evaluation of grapefruit extract for the prevention of paracetamol-induced hepatotoxicity after overdose in rats

  2015cites this paper
• Mixture effects between different azoles and β-naphthoflavone on the CYP1A biomarker in a fish cell line.

  2015cites this paper
• Drug, Nutrient, and Exercise Interactions

  2015cites this paper
• Kinetic and time-dependent features of sustained inhibitory effect of myricetin on folate transport by proton-coupled folate transporter.

  2015cites this paper
• Sustained inhibition of proton-coupled folate transporter by myricetin.

  2015cites this paper
• Nutrition for elite athletes

  2015cites this paper
• Drug–Drug Interaction: From Bench to Drug Label

  2015cites this paper
• Evidence-Based Validation of Herbal Medicine : Farm to Pharma

  2015cites this paper
• Drug Metabolism, Transport, and Pharmacogenomics

  2015cites this paper
• Chemical mixtures and interactions with detoxification mechanisms and biomarker responses in fish

  2015cites this paper
• Comparative inhibitory potential of selected dietary bioactive polyphenols, phytosterols on CYP3A4 and CYP2D6 with fluorometric high-throughput screening

  2015cites this paper
• Pharmacology in the PICU

  2014influential citation
• Cytoplasmic hybrid (cybrid) cell lines as a practical model for mitochondriopathies

  2014cites this paper
• Review article. Assessing clinical evidence of drug interactions between citrus juices and cyclosporine

  2013cites this paper
• Pharmacokinetic interaction study between quercetin and valsartan in rats and in vitro models

  2013cites this paper
• Effect of Repeated Wuniu Early Tea Administration on the CYP450 Activity Using a Cocktail Method

  2013cites this paper
• Elevated international normalized ratio with the consumption of grapefruit and use of warfarin

  2013cites this paper
• Transporters and Drug-Drug Interactions: Important Determinants of Drug Disposition and Effects

  2013cites this paper
• In Vitro interactionsof plant phenolic compounds and antiparasitic drugs with drug metabolising enzymes and transporters

  2012cites this paper
• Detoxification Mechanisms in Fish - Regulation and function of biotransformation and efflux in fish exposed to pharmaceuticals and other pollutants

  2012cites this paper
• Botanical-Drug Interactions: A Scientific Perspective

  2012cites this paper
• Knowledge and awareness of food and drug interactions (FDI): a survey among health care professionals

  2012cites this paper
• DDI Risk Assessment and Evaluation in Pharmaceutical Development: Interfacing Drug Metabolism and Clinical Pharmacology

  2012cites this paper
• Established HPLC Fraction Analysis to Predict Furanocoumarin‐Based Herb–Drug Metabolic Interactions

  2012cites this paper
• Design and synthesis of novel p38α MAP kinase inhibitors: discovery of pyrazole-benzyl ureas bearing 2-molpholinopyrimidine moiety.

  2012cites this paper
• Clinical Pharmacology in Old Persons

  2012cites this paper
• Drug Interaction Considerations Throughout Drug Development

  2011cites this paper
• An overview of interactions between grapefruit juice and drugs

  2011cites this paper
• Cocktail effects on biomarker responses in fish.

  2011cites this paper
• [Clinical relevance of drug interactions].

  2011cites this paper
• Lead Content in Pot Marigold (Calendula officinalis L.) Inflorescences and Leaves: Impact of Precipitations and Vicinity of Motorway

  2011cites this paper
• Discovery of a novel class of non-ATP site DFG-out state p38 inhibitors utilizing computationally assisted virtual fragment-based drug design (vFBDD).

  2011cites this paper
• Potential risks resulting from fruit/vegetable-drug interactions: effects on drug-metabolizing enzymes and drug transporters.

  2011cites this paper
• Hypertensive Urgency Associated With Xenadrine EFX Use

  2011cites this paper
• Effect of maturity, processing, and storage on the furanocoumarin composition of grapefruit and grapefruit juice.

  2011cites this paper
• Effect of tea beverages on aldehyde oxidase activity.

  2011cites this paper
• The use of herbal preparations as complementary and alternative medicine (CAM) in a sample of patients with cancer in Jordan.

  2010cites this paper
• Overcoming Multidrug Resistance in Human Cancer Cells by Natural Compounds

  2010cites this paper
• In vitro inhibitory effect of West African medicinal and food plants on human cytochrome P450 3A subfamily.

  2010cites this paper
• Fruit juice inhibition of uptake transport: a new type of food-drug interaction.

  2010cites this paper
• The Clinical Pharmacology of Ageing

  2010cites this paper
• Method to quantify the effect of passivation layer in bio-impedance sensors

  2009cites this paper
• 1 Clinical pharmacology of ageing

  2009cites this paper
• ADVERSE DRUG REACTIONS AND INTERACTIONS

  2009cites this paper
• hypertension8; primary prevention of ischaemic stroke9; secondary prevention for patients with coronary and other atherosclerotic vascular disease10; cardiovascular disease prevention in women11. There were also reported results of the low-fat dietary pattern and risk of cardiovascular disease of th

  2008cites this paper
• Clinically Significant Grapefruit Juice-Drug Interactions

  2008influential citation
• New Era in Drug Interaction Evaluation: US Food and Drug Administration Update on CYP Enzymes, Transporters, and the Guidance Process

  2008cites this paper
• Pharmacotherapy of insomnia

  2008cites this paper
• Effects of plant sterols on human multidrug transporters ABCB1 and ABCC1.

  2008cites this paper
• Pharmacological Principles in Treating Neurological Disease

  2008cites this paper
• Potential of Pharmacokinetic Profiling for Detecting Herbal Interactions with Drugs

  2008cites this paper
• Daily Dose effect of Valerian root extract on some Neurotransmitter contents in different Brain areas of male Albino Rats

  2007cites this paper
• A strategy for controlling potential interactions between natural health products and chemotherapy: a review in pediatric oncology.

  2007cites this paper
• Interacciones medicamentosas: aproximación para establecer y evaluar su relevancia clínica

  2007cites this paper
• Risks of Herbal Remedies: More of the Bad and the Ugly

  2007cites this paper
• Management of Grapefruit-Drug

  2006cites this paper
• Variation in Furanocoumarin Content and New Furanocoumarin Dimers in Commercial Grapefruit (Citrus paradisi Macf.) Juices

  2006cites this paper
• Diet/Nutrient Interactions with Drug Transporters

  2006cites this paper
• Management of Drug Interactions with Grapefruit

  2006cites this paper
• The Landscape of Botanical Medicine Utilization and Safety

  2006cites this paper
• Diabetes, Obesity, and Metabolic Syndrome

  2006cites this paper
• Drug–Drug, Drug–Dietary Supplement, Drug–Citrus Fruit, and Other Food Interactions_Labeling Implications

  2006cites this paper
• Everolimus drug interactions: application of a classification system for clinical decision making

  2006cites this paper
• Drug Interactions of Grapefruit and Other Citrus_What Have We Learned

  2006cites this paper
• EFFECT OF GRAPEFRUIT JUICE ON P-GLYCOPROTEIN ACTIVITY

  2006cites this paper
• DISTINCT ROLE OF BILOBALIDE AND GINKGOLIDE A IN THE MODULATION OF RAT CYP2B1 AND CYP3A23 GENE EXPRESSION BY GINKGO BILOBA EXTRACT IN CULTURED HEPATOCYTES

  2006cites this paper
• Effect of Allium sativum on cytochrome P450 and possible drug interactions

  2006cites this paper
• Next revolution in the molecular theranostics of infectious diseases: microfabricated systems for personalized medicine

  2006cites this paper
• Rasagiline (TVP-1012): a new selective monoamine oxidase inhibitor for Parkinson's disease.

  2006cites this paper
• Management of grapefruit-drug interactions.

  2006cites this paper
• Guidance for Industry Drug Interaction Studies — Study Design , Data Analysis , and Implications for Dosing and Labeling DRAFT GUIDANCE

  2006influential citation
• Grapefruit‐Drug Interactions: Can Interactions With Drugs Be Avoided?

  2006influential citation
• Interaction of grapefruit juice and calcium channel blockers.

  2006cites this paper
• Effect of grapefruit juice on cytochrome P450 2A6 and nicotine renal clearance

  2006influential citation
• Effect of grapefruit juice in relation to human pharmacokinetic study.

  2006cites this paper
• Progress and dilemma of contemporary clinical pharmacology.

  2005cites this paper
• The interaction of dietary supplements with antithrombotic agents: scope of the problem.

  2005cites this paper
• What's the scoop with grapefruit?

  2005cites this paper
• Natural health products and drug disposition.

  2005cites this paper
• Mechanistic basis of adverse drugreactions: the perils of inappropriate dose schedules

  2005cites this paper
• Potential for toxicity with use of bitter orange extract and guarana for weight loss

  2005cites this paper
• Traditional Aqueous Kava Extracts Inhibit Cytochrome P450 1A2 in Humans: Protective Effect Against Environmental Carcinogens?

  2005cites this paper
• Effects of dietary chemopreventive phytochemicals on P-glycoprotein function.

  2005cites this paper
• The potential impact of the use of homeopathic and herbal remedies on monitoring the safety of prescription products

  2005cites this paper
• Safety issues associated with herbal ingredients.

  2005cites this paper
• Herbs and alternative therapies: Relevance to hypertension and cardiovascular diseases

  2005cites this paper